Neurological Devices Panel meeting postponed
This article was originally published in The Gray Sheet
Executive Summary
FDA postpones Oct. 31 meeting of Neurological Devices Advisory Panel to a date yet to be determined. The panel will review clinical data and discuss questions about Neuronetics' NeuroStar TMS system as a potential treatment for depression, says Peter Anastasiou, the company's VP-marketing. CDRH "will further evaluate data relevant to the topic," according to the agency's website...
You may also be interested in...
Neuro advisory panel to meet
FDA reschedules for Jan. 26 a meeting of its Neurological Devices Panel to discuss Neuronetics' NeuroStar TMS system as a potential treatment for major depressive disorder, according to the firm. The meeting originally was scheduled for Oct. 31, but was postponed to allow for further evaluation of data on the topic, according to CDRH (1"The Gray Sheet" Oct. 16, 2006, In Brief)...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.